Back to search

Article

Tirzepatide cardiovascular benefits and adverse events assessment: a Bayesian network meta-analysis

2024-04-02

Abstract excerpt

<title>Abstract</title> <p>Objective To comprehensively assess the cardiovascular benefits and adverse events of tirzepatide (including different control groups, different dosages and different patients). Method A systematic search was conducted on PubMed, Web of Science,The Cochrane Library and ClinicalTrials.gov. Randomized controlled trials (RCTs) of at least 26 weeks that compared tirzepatide (TZP) at doses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
45a1deef-39d8-593f-9f10-17aad6c37f52
DOI
10.21203/rs.3.rs-4159026/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tirzepatide cardiovascular benefits and adverse events assessment: a Bayesian network meta-analysisDOI 10.21203/rs.3.rs-4159026/v1
Cardiovascular Outcomes of Tirzepatide vs Semaglutide in Obesity Without Type 2 Diabetes: A Matched Cohort StudySemantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Tirzepatide and potential use for metabolically healthy obesity.Semantic proximity
Beyond Cardiology's Pillars: A Network Meta-Analysis Comparing the Recombinant Zoster Vaccine (Shingrix/RZV) with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Prevention of Major Adverse Cardiovascular Events and Dementia in Adults Aged ≥50 YearsSemantic proximity
The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysisSemantic proximity
NMA: Network meta-analysis based on multivariate meta-analysis and meta-regression models in RSemantic proximity
Class-Wide Disproportionate Reporting of Impaired Gastric Emptying Across Nine Glucagon-Like Peptide-1 Receptor Agonist Products: A Signal-Detection Analysis of the FDA Adverse Event Reporting SystemSemantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Evaluation of statin indication and dose intensification among type 2 diabetic patients at Tikur Anbessa Specialized HospitalSemantic proximity
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort studySemantic proximity
Gastrointestinal adverse events associated with Riociguat: A pharmacovigilance study based on FDA adverse event reporting systemSemantic proximity
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)Semantic proximity
Select a neighboring publication to make it the new centre.